Meet the media team
Find a media contact in your region
Learn more
Total 4 Results for:
Showing 4 out of 4 results
15 mai 2026
Herbert Smith Freehills Kewei advises Fosun Pharma on option agreement with AriBio for territories including the US, Europe and Japan
Leading global law firm Herbert Smith Freehills Kramer and its China joint operation partner Kewei have advised China pharmaceutical giant Fosun Pharma …
3 mars 2026
Herbert Smith Freehills Kramer advises PlasmaLeap Technologies on its A$30 million Series A Capital Raise
HSF Kramer’s venture capital team has advised PlasmaLeap Technologies Pty Ltd on its A$30 million Series A capital raise, led by the Gates Foundation, …
12 décembre 2025
Herbert Smith Freehills Kewei advises Fosun Pharma on international licence agreements with Pfizer and Sitala
International leading law firm Herbert Smith Freehills Kramer and its China joint operation partner Kewei have advised China’s pharmaceutical leader …
20 août 2025
Herbert Smith Freehills Kramer advises Ampol on its A$1.1 billion proposed acquisition of EG Australia
Herbert Smith Freehills Kramer is pleased to be advising Ampol on its $1.1 billion proposed acquisition of EG Australia under a share purchase agreement.
Showing 4 out of 4 results
Code≠Law: In a race between innovation and oversight, which one sets the pace?
The second chapter of our series explores the forces shaping AI’s next phase and what they mean for business
Read our latest report